Back
Axsome Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
64
AXSM
Axsome Therapeutics
Last Price:
93.21
Seasonality Move:
57.5%
Sell
40
ALNY
Alnylam Pharmaceuticals
Last Price:
296.71
Seasonality Move:
11.91%
Buy
64
Axsome Therapeutics (AXSM)
is a Buy
Is Axsome Therapeutics a Buy, Sell or Hold?
- The current Axsome Therapeutics [AXSM] share price is $89.97. The Score for AXSM is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- AXSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $300.55. The Score for ALNY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $89.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $300.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.98 | Sell |
| Relative Strength Index (14 RSI): | 53.32 | Buy |
| Chaikin Money Flow: | 279889 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (86.13 - 92.99) | Buy |
| Bollinger Bands (100): | (78.06 - 90.68) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.76 | Buy |
| Relative Strength Index (14 RSI): | 75.52 | Buy |
| Chaikin Money Flow: | 1043301 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (266.78 - 282.26) | Buy |
| Bollinger Bands (100): | (196.41 - 285.77) | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.61 | Buy |
| 20-day SMA: | 88.94 | Buy |
| 50-day SMA: | 89.05 | Buy |
| 200-day SMA: | 82.08 | Buy |
| 8-day EMA: | 87.08 | Buy |
| 20-day EMA: | 88.11 | Buy |
| 50-day EMA: | 87.93 | Buy |
| 200-day EMA: | 81.74 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 280.35 | Buy |
| 20-day SMA: | 275.91 | Buy |
| 50-day SMA: | 270.69 | Buy |
| 200-day SMA: | 200.56 | Buy |
| 8-day EMA: | 283.96 | Buy |
| 20-day EMA: | 277.03 | Buy |
| 50-day EMA: | 266.03 | Buy |
| 200-day EMA: | 219.81 | Buy |
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.95 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.37 per share, and an increase next year of $3.87 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.32 per share, and an increase next year of $0.76 per share.
Axsome Therapeutics Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||